Payer perspective regarding decisions for covering the costs of molecular assays in oncology and reimbursing oncologists for treatments provided to patients while navigating long turnaround times ...
The study revealed that out of 140,528 pregnancies, 5,879 were initially identified as high-risk through traditional early trimester screenings. However, by integrating NIPT with the pregascreen ...
Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback